Overview
Mark McKenna serves as Venture Partner at ARCH Venture Partners [6]. McKenna is Chairman and Chief Executive Officer of Mirador Therapeutics, a precision medicine company focused on immunology and inflammation [2][3]. Previously, McKenna held the position of Chairman and Chief Executive Officer of Prometheus Biosciences from 2019 to 2023 [10], a clinical stage biotechnology company acquired by Merck for $10.8 billion in June 2023 [2]. McKenna also serves as Chairman of the Board at Apogee Therapeutics [9], Board Member at NewAmsterdam Pharma Corporation [5] and Spyre Therapeutics [7], Member of the Board of Trustees at Arizona State University [4], and Senior Advisor at Fairmount Funds Management LLC [8]. McKenna holds an MBA in Management from Azusa Pacific University [12], a Bachelor of Science in Marketing from Arizona State University [13], and completed the Wharton Fellows Program [11].
Profile introduction
Mark C. McKenna is Chairman and Chief Executive Officer of Mirador Therapeutics. Mirador Therapeutics is a next generation precision medicine company focused on immunology and inflammation. He previously served as Chairman and Chief Executive Officer of Prometheus Biosciences (Nasdaq: RXDX) from 2019-2023. Prometheus Biosciences was a clinical stage biotechnology company which created the first precision therapeutics for immune-mediated diseases which was acquired by Merck for $10.8B in June of 2023. The acquisition represented the largest M&A takeout of pre-phase 3 company. Mr. McKenna…
Career history
- Chairman and Chief Executive OfficerMar 2024 to presentMirador Therapeutics
- Member Board of TrusteesJun 2025 to presentArizona State University
- Board MemberJul 2024 to presentNewAmsterdam Pharma Corporation
- Venture PartnerFeb 2024 to presentARCH Venture Partners
- Board MemberFeb 2024 to presentSpyre Therapeutics
- Senior AdvisorOct 2023 to presentFairmount Funds Management LLC
- Chairman of the BoardAug 2023 to presentApogee Therapeutics
- Chairman and Chief Executive OfficerAug 2019 to Jul 2023Prometheus Biosciences, Inc.
Education
Wharton Fellows Program2014 - 2017The Wharton School
- MBA, Management2004 - 2008Azusa Pacific University
Bachelor of Science (B.S.), MarketingW. P. Carey School of Business, Arizona State University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.